Flow diversion aneurysm treatment market to grow by $2.43b until 2028

It is estimated to grow at a 9.34% CAGR within the forecast period.

The global market for flow diversion aneurysm treatment is expected to grow by $2.43b until 2028 at an estimated compound annual growth rate (CAGR) of 9.34%.

A report by Technavio revealed that the market is experiencing significant growth amidst the rising prevalence of intracranial aneurysms as more people get diagnosed with the condition due to improved imaging techniques and public health campaigns.

Moreover, the market is driven by the growing popularity of minimally invasive treatments which offer fewer risks and faster recovery time compared to traditional brain surgery.

Meanwhile, stringent regulatory hurdles serve as a challenge impeding market growth, as well as procedural complexity and high treatment costs.

“Flow diversion procedures can be expensive, limiting access for some patients. The lack of proper reimbursement policies in certain regions further restricts affordability,” The report said.Furthermore, Technavio mentioned that the treatment needs highly skilled surgeons and specialised equipment, which may not be readily available in hospitals.